ArticleJCO precision oncology2022

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.

Iedan R N Verly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.